Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers

Real-world follow-up data from 465 patients add to evidence from earlier randomized trials.

  • By

  • Kathryn Wighton

  • June 27, 2026

  • 3 min

Share

Original Source(s)

Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers

  • by Kathryn Wighton

  • June 27, 2026

Related Content

Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis

Editorial: introducing special collection on cancer and cardiovascular disorders

Efficacy and safety of quadruple therapy versus triple therapy in patients with heart failure with preserved ejection fraction: a propensity score-matched real-world study